Market Report, "Japan Pharmaceuticals & Healthcare Report Q2 2014", Published
Japan's pharmaceutical expenditure forecast has been upgraded marginally on the back of an increase in medical fees. We highlight that its ageing population remains a key driver of increasing demand for pharmaceuticals. From a sub-sector perspective, slow generic drug uptake continues to support the use of patented drugs, while the liberalisation of the over-the-counter medicine sector will also boost pharmaceutical sales. Despite this, the slow-growing economy remains a downside risk to our forecast.